<DOC>
	<DOCNO>NCT01088360</DOCNO>
	<brief_summary>The purpose study compare incidence rate target infection , malignancy mortality among patient rheumatoid arthritis treat abatacept treated anti-rheumatic medication .</brief_summary>
	<brief_title>Safety Study Abatacept Treat Rheumatoid Arthritis ( B )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Signed informed consent Diagnosis rheumatoid arthritis &gt; 18 year index treatment initiation switch Starting treatment abatacept new diseasemodifying antirheumatic drug ( include switch add ) biologic disease modify drug . Read/write English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>